Navidea Biopharmaceuticals Inc., of Dublin, Ohio, said it closed an underwritten public offering of 8 million common shares priced at 75 cents apiece, including 4 million shares that were placed with John Kim Scott, Jr., a principal stockholder, at the public offering price.